News

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.
The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...
Rooted in Varda’s early photography, the Musée Carnavalet’s show illuminates and clarifies the singular nature of a great ...
NASA officials remain eager for Starliner to begin these regular crew rotation flights, even as its sole destination, the ISS ...
In Ari Aster’s dark comedy, Joaquin Phoenix plays the sheriff of a New Mexico town riven by political clashes and pandemic ...
Venture capital companies remained the most active space investors in recent months, contributing 77% of 2025 funding in the ...
In this week’s edition of The Prototype, we look at a new company building automated construction equipment, a potential new ...
Firms downgrade 2025 outlook, isocyanate start-up launches, hydrogen projects advance, and more ...
Synopsys has completed the acquistion of Ansys. The $35bn deal brings Ansys' predictive simulation and analysis tools into ...
The alliance brings together Cellular Origins, a company focusing on applying robotics and other forms of automation to CGT ...
AST SpaceMobile (ASTS), Planet Labs (PL), and BlackSky (BKSY) have been on a tear lately. Since early April, all four of these names have more than doubled – in just three months – led by a nearly 215 ...